TY - JOUR
T1 - Incidence of stent fractures and patency after femoropopliteal stenting with the nitinol self-expandable SMART stent
T2 - A single-center study
AU - Trabattoni, Daniela
AU - Agrifoglio, Marco
AU - Cappai, Antioco
AU - Bartorelli, Antonio L.
PY - 2010/9
Y1 - 2010/9
N2 - OBJECTIVE: The aim of the study was to investigate long-term incidence of stent fractures and patency after femoropopliteal stenting. METHODS: Sixty consecutive patients (mean age 70 ± 7 years) were treated with implantation of single (31 patients) or multiple (29 patients) self-expandable nitinol SMART stents (Cordis, Miami, Florida, USA; mean stent length 108.8 ± 73 mm) between year 2000 and 2005. At a mean follow-up of 66 ± 20 months, 37 patients (85% men, mean age 71 ± 7 years) were alive and underwent plain radiograph and color-coded duplex sonography. A peak systolic velocity was measured proximally, intrastent and distally. RESULTS: Stent fractures were detected by radiograph in three of the 39 (7.7%) legs (mean stented segment 207 ± 64 mm). In one case, a moderate strut fracture was associated with in-stent occlusive restenosis confirmed by angiography. Color-coded duplex sonography revealed a mean in-lesion peak systolic velocity of 73 ± 35 cm/s, six (15%) in-stent restenoses and four (11%) total occlusions. Primary patency rate 5 years after nitinol SMART stent implantation was 74.6%. Patients symptomatic for claudication or presenting with diagnosis of in-stent restenosis underwent angiography. CONCLUSION: Long-term femoral SMART stenting showed minimal incidence of fractures compared with previously published data with different stent types. In-stent restenosis and occlusive restenosis seem to be correlated with stented segment length.
AB - OBJECTIVE: The aim of the study was to investigate long-term incidence of stent fractures and patency after femoropopliteal stenting. METHODS: Sixty consecutive patients (mean age 70 ± 7 years) were treated with implantation of single (31 patients) or multiple (29 patients) self-expandable nitinol SMART stents (Cordis, Miami, Florida, USA; mean stent length 108.8 ± 73 mm) between year 2000 and 2005. At a mean follow-up of 66 ± 20 months, 37 patients (85% men, mean age 71 ± 7 years) were alive and underwent plain radiograph and color-coded duplex sonography. A peak systolic velocity was measured proximally, intrastent and distally. RESULTS: Stent fractures were detected by radiograph in three of the 39 (7.7%) legs (mean stented segment 207 ± 64 mm). In one case, a moderate strut fracture was associated with in-stent occlusive restenosis confirmed by angiography. Color-coded duplex sonography revealed a mean in-lesion peak systolic velocity of 73 ± 35 cm/s, six (15%) in-stent restenoses and four (11%) total occlusions. Primary patency rate 5 years after nitinol SMART stent implantation was 74.6%. Patients symptomatic for claudication or presenting with diagnosis of in-stent restenosis underwent angiography. CONCLUSION: Long-term femoral SMART stenting showed minimal incidence of fractures compared with previously published data with different stent types. In-stent restenosis and occlusive restenosis seem to be correlated with stented segment length.
KW - femoral stenting
KW - long-term patency
KW - percutaneous transluminal angioplasty
KW - stent fractures
UR - http://www.scopus.com/inward/record.url?scp=77955232235&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77955232235&partnerID=8YFLogxK
U2 - 10.2459/JCM.0b013e3283383370
DO - 10.2459/JCM.0b013e3283383370
M3 - Article
C2 - 20216226
AN - SCOPUS:77955232235
VL - 11
SP - 678
EP - 682
JO - Journal of Cardiovascular Medicine
JF - Journal of Cardiovascular Medicine
SN - 1558-2027
IS - 9
ER -